- prodrugs that react to generate active sulfanilamides
- for intestinal infections, ==ulcerative colitis==, or reduction of bowel flora
- for Crohn disease
## DMARDs
### Mechanism: 
- A csDMARD: 
	- metabolized to sulfapyridine and 5-aminosalicylic acid 
		- inhibiting T cell response to concanavalin and B cell proliferation. 
		- inhibit inflammatory cytokine production & release by monocytes/macrophages. 
### Indications: 
- RA, reduces radiologic disease progression, reactive arthritis, JIA, PsA, AS, inflammatory bowel disease, gastrointestinal Beh√ßet disease, and HLAB27positive anterior uveitis with AS. 
### Adverse Effects: 
- nausea, vomiting, headache, and rash.
![[Pasted image 20230314222607.png]]